Biotech executive Matthew Panuwat bought options on another drug company's stock and earned a windfall of $120,000.
The Securities and Exchange Commission now says he committed insider trading, even though he didn't buy his employer's stock and didn't have inside information about the company he bet on.
The case, which goes to trial next month, has become the latest test of insider trading law. Congress has never defined what it means, leaving regulators and courts across the country to decide what qualifies, a volatile process that sometimes leads appellate courts to rein in what they see as excesses.
Defense lawyers have dubbed Panuwat's case the first involving "shadow insider trading," a label that describes executives making well-timed bets in the shares of other companies. The SEC alleges Panuwat purchased options tied to the shares of Incyte, a rival drugmaker because he knew they would pay off when the market heard Pfizer was buying his company, Medivation, in 2016.
No court has ever tackled the idea that executives can go too far when they deploy their specialized knowledge or expertise to trade in the shares of rivals, said Karen Woody, a professor at the Washington and Lee University School of Law.
"I do think this is a push of the law and they are seeing if they can get a court to bless what is a bit of a stretch of the existing parameters," Woody said of the SEC's case.
Denne historien er fra February 22, 2024-utgaven av Mint Mumbai.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra February 22, 2024-utgaven av Mint Mumbai.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Buying Online? Beware Of these deceptive patterns
Deceptive prompts in apps—ways to coerce people into spending more time or money—are on the rise. Here's how to identify them
As AI gets real, slow and steady wins the race
Companies head into 2025 with careful deliberation when it comes to using AI
Why the Earth Is Not a Type 1 Technological Civilization
According to one theory about how we harness energy, Type 1s have total control over planetary energy resources
Our legislative frameworks must adapt to the rise of AI
Probabilistic digital systems complicate guilt assignment but we'll need tight controls against major harms
Take tax action for Viksit Bharat in the Union budget for 2025-26
The government could take major steps towards its worthy goal of a tax regime that's simple, predictable and competitive
Trump's US mustn't repeat its profiling of Chinese scientists
Espionage suspicions could lead the US to lose its war for talent
The rise of Trump poses a paradox of higher education
An elitist college system seems to have deepened divisions in the US and this may hold lessons for India too
There's a case for heavy taxes on MNC royalties
Royalty payments to MNCs by their local units have been rising-even going above dividend payouts in some cases. India needs shareholder vigilance and fiscal action to curb excesses
Financial frauds evolve fast but we can still safeguard ourselves
While technology has transformed how scamsters operate, reliable ways exist to dodge their traps
Smart-beta funds: A guide to balancing your portfolio
Tailor-made strategies will help you navigate the market cycles better and optimize returns
